Cameron tells Starmer ‘progress possible' on dementia after loss of his mother
The former prime minister said that there is 'still a mountain to climb', as he recalled the 'full destructive force' of the illness.
Writing in the Sunday Times, Lord Cameron also announced that he had returned to his position as president of Alzheimer's Research UK, having stepped down when he became foreign secretary in 2023.
In 2015 I set a bold challenge: to find a treatment for dementia by 2025. A decade of progress has delivered this, but we still have a mountain to climb.
Today I'm proud to return as President of @AlzResearchUK, and more determined than ever. #ForACure. https://t.co/xivwUJCD2h
— David Cameron (@David_Cameron) March 9, 2025
Lord Cameron wrote: 'The very future of our health service rests on how we respond to the growing dementia crisis.
'In short, there is still a mountain to climb. But my message to Sir Keir Starmer and his team is that progress is possible if they're committed to it.'
He said that his 'dear mother' Mary Cameron died last month.
'We were in a lucky position as a family to be able to pay for carers in her home,' he said.
'But no matter how good the care, the full destructive force of Alzheimer's is shocking and saddening in equal measure. Memory goes; movement goes; eventually speech and almost all cognition and recall goes.'
Lord Cameron said that breakthroughs in treatment were too late for his mother, 'but soon that won't be the case for people living with dementia'.
Alzheimer's disease is a type of dementia. According to Alzheimer's Research, almost one million people in the UK have dementia.
Hilary Evans-Newton, chief executive at Alzheimer's Research UK, said: 'We are thrilled to welcome Lord Cameron back as president of Alzheimer's Research UK, continuing the vital mission he set in motion with the Prime Minister's Dementia Challenge.
'No world leader has done more to put dementia on the global agenda, helping to secure vital research funding and drive awareness of a condition that affects millions.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
More women get Alzheimer's than men. It may not just be because they live longer
Working three full-time jobs, raising kids and tending her blooming garden: Angeleta Cox says her mother, Sonia Elizabeth Cox, never really slowed down all her life. Then, at the age of 64, a diagnosis of Alzheimer's slammed the brakes on the vibrant life she'd painstakingly built after immigrating to Canada from Jamaica in 1985. "The onset of the symptoms came on very fast," Cox said of her mother. "She forgot my dad first, and she wasn't able to respond to my brother, so I became a care provider for her," said Cox. Sonia Elizabeth died late last year, after years of battling Alzheimer's. More women get diagnosed with Alzheimer's disease than men. In developed countries, studiessuggest about two-thirds of people with Alzheimer's are women. It's a pattern seen in Canada, too, where women account for almost two-thirds of people with dementia, according to the last count from Statistics Canada. Scientists long explained this with a simple demographic fact: women tend to live longer, and age is a strong risk factor for the development of dementia. But that understanding is now changing. While age is still considered an important risk, scientists are increasingly realizing other aspects — both biological and sociological — may play an important role in making women susceptible to developing Alzheimer's. WATCH | Alzheimer's in women linked to early menopause, say scientists: "I think we're beginning to be at an inflection point," said Gillian Einstein, who studies how sex and gender can influence an individual's risk for developing dementia, as part of the Canadian Consortium on Degeneration and Aging. "I think you can feel it here," she said, gesturing around at the Metro Toronto Convention Centre, where leading Alzheimer's researchers gathered for the annual Alzheimer's Association International Conference (AAIC) in late July. "There's so many more sessions on sex differences, or women's health." Hormones, babies and menopause Alzheimer's disease is the most common form of dementia in the world, according to the World Health Organization. It causes symptoms like memory loss, confusion and personality changes. In Canada, Alzheimer's is also the ninth leading cause of death, according to Statistics Canada. One factor scientists now know about: the timing of key hormonal changes, like when women first get their periods, how long they are fertile for, and the age they reach menopause. "There are a lot of studies in the UK Biobank, for example, showing that the longer the reproductive [period] women have, the lower the risk is of late-life Alzheimer's disease. Having [one to] three children also seems to lower the risk of Alzheimer's," said Einstein, referring to a large database containing the health and genetic information from 500,000 volunteers. Premature menopause, which happens before the age of 40, and early menopause (between the ages of 40 and 44) are also key risk factors, said Dr. Walter Rocca, who studies the differences in the way men and women age at the Mayo Clinic in Rochester, Minn. "So these women should be treated appropriately to avoid these deficiency of hormones," said Rocca, who presented research on the topic at the AAIC conference. What that treatment looks like could vary widely, Rocca said, based on the patient, as well as the cost and availability of the drug. Some main treatment approaches include pills, patches, gels and creams containing the hormone estrogen, which has been shown to have neuroprotective effects but naturally declines during menopause. The risk of cognitive decline with early or premature menopause exists whether the menopause happened naturally, or caused by their ovaries being removed, says Einstein. She pointed to a study she co-authored, which analyzed data from over 34,000 women from the UK Biobank. "Women who had their ovaries removed prior to the age of 50 will also have an increased risk of Alzheimer's," she said. More inclusive research Researchers are playing catch-up, when it comes to understanding women's risk for Alzheimer's, says Natasha Rajah, a Tier 1 Canada Research Chair in Sex, Gender and Diversity in Brain Health, Memory and Aging at Toronto Metropolitan University. "Not only have we not been included in the research, but even in the clinical trials, we're not represented," she said. "It makes no sense when you think this disease affects more females than males." She's hoping to fill in some of those blanks. She's currently conducting the Canadian Brain Health at Midlife and Menopause study (BHAMM), which searches for early signs of the disease through brain scans and blood samples at mid-life. "We're trying to understand whether or not menopause is a window at which some females might be showing early signs of Alzheimer's disease," she said. If they are identifiable, those showing early signs of disease could get treatment or alter their lifestyles to better age, according to Rajah. There is no cure for Alzheimer's, but treatments include drugs that can help manage symptoms. Lifestyle changes, like physical exercise and a brain-healthy diet have also been shown to help brain health in older adults at risk of cognitive decline. She's also hoping to capture a more diverse population group in her research to better understand risk factors associated with race. Alzheimer's research in Western countries like the U.S. and Canada hasn't always been diverse, says Rajah. "With the BHAMM study, we're trying to reach out to as many communities as possible because we want to be more representative in our research." Different choices Looking back, Cox says she now realizes surgically induced menopause was a risk factor for her mother, who had a full hysterectomy after having fibroids in her 30s. The knowledge has led her to make different choices for herself — like reducing stress and taking care of her mental health. She's also now aware of how her own hormones can interact with Alzheimer's risk. "When it came time for me to deal with my fibroids that I had, I chose not to have a full hysterectomy." She's also passing down the knowledge to her daughter — and sharing it with other members of the Black community who have been impacted by Alzheimer's, through the Pan African Dementia Association. She's hoping researchers will find out more about risk factors for women developing Alzheimer's — so fewer women and families have to live through what her mom did. "When it impacts women, it impacts the entire family and the community," she said.
National Geographic
4 hours ago
- National Geographic
‘Superagers' seem to share this one key personality trait
The brains of superagers are different from the rest of us. Here's what 25 years of research reveals about why some people remain sharp well into their 80s and 90s. There's no one lifestyle linked to staying impressively sharp as you age—but a new study suggests there is at least one personality trait: gregariousness. Brain scans and post-mortem examinations of superagers reveal several differences that may explain their outgoing behavior. Photograph by Britt Erlanson, Getty Images What if you could stay sharp in old age? We may be closer to understanding how some people over 80 became what's known as 'superagers'—meaning they have the cognitive function of someone decades younger. In a new paper published in the journal Alzheimer's & Dementia, researchers at Northwestern University reveal what they've learned in the last 25 years of studying more than a hundred superagers—and analyzing some 77 post-mortem superager brains. The new paper shows that the brains of superagers share a host of characteristics that may allow them to retain their cognitive function. And while there's still much to understand about whether lifestyle choices play a role, researchers did observe one personality trait that all superagers seem to share: they're sociable. (Can aging be cured? Scientists are giving it a try.) The findings further contributed to developing a 'distinct neurobiological signature' for identifying superagers: You might be one if you're 80 or older and can recall at least nine words about 30 minutes after someone reads you a 15-word list. Eventually, this research could build the foundation for future neurodegenerative disease interventions. 'One creative and novel way to understand or prevent Alzheimer's disease is to study those that don't get it,' says Tamar Gefen, a study author and assistant professor of psychiatry and behavioral sciences at Northwestern University. That's why superagers are so fascinating, she says. 'Their memories are just outstanding even compared to their peers.' Superagers are outgoing—and tenacious You might not be able to control the characteristics of your brain. But the Northwestern researchers have studied whether there are any lifestyle or personality traits that superagers share, and just one trait stood out—gregariousness. 'These are people living life on their own terms,' Gefen says. Whether that means volunteering in communities, or having 'multiple romantic partners,' as some study participants did, it's clear superagers are connected by their values of autonomy and connection, adds Gefen. Her team found potential biological underpinnings for these differences. The study shows superagers have more of a certain type of neurons associated with sociability compared to their peers—and surprisingly, more of these neurons than people much younger. Known as von Economo neurons, they are found in the anterior cingulate gyrus of the brain, which plays a role in emotion and cognitive processing. (7 simple science-backed rules for living longer.) 'You really only find these in species that are social, like whales,' says Joel Kramer, a professor of neuropsychology at the University of California, San Francisco. His team is currently studying frontotemporal dementia patients, and so far found a 'striking loss' of von Economo neurons in those who are less empathetic. Indeed, the study notes these neurons have been found in emotional and social animals like great apes, elephants, and cetaceans like whales or dolphins. Animals 'that have strong connections tend to outlive and outsmart their peers. It's like the pack culture,' Gefen says. Having a thicker anterior cingulate gyrus also suggests superagers are more tenacious. This is a region that is 'traditionally not associated with memory, but motivation,' says Alexandra Touroutoglou, an assistant professor of neurology who also studies superagers at Harvard University. 'This may reflect that superagers may be more willing to exert effort in the face of challenges.' Northwestern researchers Sandra Weintraub and Marsel Mesulam founded the SuperAging Research Program more than 25 years ago after they examined a post-mortem brain of an 81-year-old woman with the cognitive function of someone in her 50s that they had received from the University of Miami's Miami Brain Endowment Bank. This finding challenged the prevalent idea that severe cognitive decline is unavoidable with age. Fast forward decades later, and Northwestern has built up a brain bank of its own with 77 post-mortem brains, says Gefen, which she finds particularly exciting, as autopsy is considered the gold standard for identifying the causes and progression of disease. (When does old age begin? Science says later than you might think.) One key finding from the study is that cortical thinning, or brain shrinkage, in superagers is much slower than their peers—which may explain why they're less prone to neurodegeneration associated with conditions from dementia to Parkinson's disease. Over an 18-month period, superager cortical thickness was reduced by 1.06 percent, while peers' reduced by 2.24 percent. The researchers speculate in the paper that superagers could have been born with bigger brains; however, that 'is unlikely to be the entire answer given the absence of obvious differences in skull morphology.' Additionally, superagers had a more robust cholinergic system, a neurotransmitter system associated with memory, learning, and motor function. Cholinergic neurons in the basal forebrain are thought to be among the first to show degeneration as you age. They communicate with each other via the neurotransmitter acetylcholine, which is important for alertness, explains Kramer. For example, Kramer says the reason why you might feel 'a little dopey and not so sharp' when you take anti-seasickness medication is because it reduces acetylcholine. On the other hand, modern dementia therapeutics like donepezil slow the breakdown of acetylcholine by inhibiting an enzyme, acetylcholinesterase, thus making you less forgetful. The Northwestern study found that among participants' acetylcholinesterase-rich neurons, superagers had less of the enzyme than their peers. This may suggest acetylcholine degrades slower among superagers, and possibly make them more resistant to worsening memory. Superager brains may also be more resistant to the changes in the brain linked to Alzheimer's. An autopsy of a 92-year-old superager in the Northwestern study showed prominent neurofibrillary tangles, a hallmark of the disease. But the superager also had a 'much greater' amount of viable, healthy neurons, which could play a 'decisive role' in memory. 'This is an important finding, because it underscores that superagers may not avoid all pathological age-related brain changes,' Touroutoglou says. 'It also shows the viable neurons may play an important role that has not been studied.' Does lifestyle make a difference? Surprisingly, the study found little difference between the cognitive performance of superagers who lived healthy lifestyles—i.e. ate well and exercised—and those who did the opposite. Still, this should be interpreted with caution, experts say. Because this isn't a controlled longitudinal study that started when people were young, 'you cannot completely know whether these sorts of behaviors are helping or not,' Gefen says. Further, other research suggests that lifestyle does indeed play a role. In 2024, for example, a commission from The Lancet estimated that up to 45 percent of dementia cases may be preventable if people adopt regular exercise or abstain from excess intoxication. 'I think it's absolutely true lifestyle matters. There's too much evidence,' Kramer says. 'The question is not, 'does everyone have to exercise?' The question is, 'if exercise and lifestyle don't explain everything, what are other things that explain this?'' Maybe it's genetics. But when it comes to superagers, currently 'we have more questions than answers,' Kramer says. Fortunately, researchers are working on this. Gefen is especially excited about the new discoveries the Northwestern brain bank may bring; for example, her team is investigating what makes von Economo neurons special and their role in disease resistance. 'You can just imagine what the future holds in that SuperAging brain bank.'
Fox News
11 hours ago
- Fox News
'Missing link' to Alzheimer's disease found in study of human brain tissue
Researchers have uncovered a new factor that could contribute to Alzheimer's disease development. A study by Harvard Medical School has identified low lithium levels in the brain as a possible trigger for the common dementia. Lithium is known to have many functions in the brain, including balancing mood-regulating chemicals, protecting neurons and managing emotional processing. It has also been used to treat bipolar disorder and depression. Now, new findings show that the metal could be a "missing link" in Alzheimer's risk, according to a Harvard press release. The researchers tested lithium's effects in mice, as well as human brain tissue and blood samples. The human brain samples were obtained in partnership with the Rush Memory and Aging Project in Chicago, which maintains post-mortem brain tissue from thousands of donors. The samples represented the full spectrum of cognitive health, ranging from no sign of disease to mild cognitive impairment to advanced Alzheimer's, the release stated. They discovered that lithium levels became lower as signs of the disease increased, showing as "greatly diminished" in advanced Alzheimer's patients. "It's the first time anyone's shown that lithium exists at a natural level that's biologically meaningful without giving it as a drug." As toxic amyloid plaques build up in the brain — a hallmark of Alzheimer's — they begin to attach to lithium, keeping it from performing its protective functions. When the mice were fed a "lithium-restricted diet," their brains' lithium levels decreased, causing accelerated aging, formation of amyloid-beta plaques, greater inflammation, memory loss and cognitive decline. "Lithium turns out to be like other nutrients we get from the environment, such as iron and vitamin C," said senior author Bruce Yankner, professor of genetics and neurology in the Blavatnik Institute at Harvard Medical School, in the release. "It's the first time anyone's shown that lithium exists at a natural level that's biologically meaningful without giving it as a drug." The researchers also discovered a new type of lithium compound — lithium orotate — that did not bind to amyloid. When mice drank water containing this compound, it helped to restore memory and reverse brain damage, even for those who had advanced signs of disease. The findings were published in the journal Nature. "What impresses me the most about lithium is the widespread effect it has on the various manifestations of Alzheimer's," said Yanker. "I really have not seen anything quite like it in all my years of working on this disease." "The idea that lithium deficiency could be a cause of Alzheimer's disease is new and suggests a different therapeutic approach." While the study did suggest that the amount of lithium in the brain could be related to amyloid beta buildup, it did have some obvious limitations, according to Ozama Ismail, Ph.D., director of scientific programs for the Alzheimer's Association in Chicago. "Animal models do not directly replicate Alzheimer's in humans; rather, they can provide some insights into the biology of disease progression and development," Ismail, who was not involved in the study, told Fox News Digital. "The mouse models have been modified to accumulate amyloid beta, a hallmark protein that builds up in the brains of people with Alzheimer's." While studies in mouse models are a "vital early step" in therapeutic research, Ismail emphasized that much more research is needed to understand the health effects of lithium levels in the brain. "Understanding if lithium can be therapeutic for Alzheimer's requires large clinical trials in representative populations," he said. Much like other major diseases, it is likely that Alzheimer's treatment will require multiple approaches combining medication and lifestyle changes, Ismail predicted. The researchers agreed that more research in human clinical trials is needed. "You have to be careful about extrapolating from mouse models, and you never know until you try it in a controlled human clinical trial," Yankner noted. "But so far, the results are very encouraging." If future studies confirm these findings, the scientists say that routine blood tests could potentially screen for lithium levels and identify people at risk. "My hope is that lithium will do something more fundamental than anti-amyloid or anti-tau therapies." In the meantime, Yankner cautioned against people taking lithium compounds "on their own." "My hope is that lithium will do something more fundamental than anti-amyloid or anti-tau therapies, not just lessening but reversing cognitive decline and improving patients' lives," he said. For more health articles, visit The study was supported by the National Institutes of Health, the Ludwig Family Foundation, the Glenn Foundation for Medical Research and the Aging Mind Foundation.
